Company Filing History:
Years Active: 2023
Title: **Inventor Profile: Dong-Gun Kim**
Introduction
Dong-Gun Kim is an innovative inventor based in Daegu, South Korea. He has made significant contributions in the field of pharmaceutical compositions, particularly focused on retinal diseases. With a keen interest in utilizing natural extracts, his research has led to the development of a unique solution beneficial for eye health.
Latest Patents
Dong-Gun Kim holds one patent, titled "Pharmaceutical composition comprising maple leaf extract for preventing or treating retinal disease." This invention relates to a pharmaceutical composition comprising a maple leaf extract or its fractions aimed at preventing or treating retinal diseases. The patent also encompasses a method for this treatment, along with a food composition designed to ameliorate symptoms associated with retinal conditions. His innovative approach highlights the potential use of maple leaf extract in both pharmaceutical and health functional food applications.
Career Highlights
Dong-Gun Kim is affiliated with the Korea Institute of Oriental Medicine, where he continues to pursue his research in natural medicine and its applications. His commitment to blending traditional knowledge with modern scientific techniques exemplifies his dedication to advancing health solutions.
Collaborations
Throughout his career, Dong-Gun Kim has collaborated with notable coworkers such as Jin Yeul Ma and Kwang Il Park. Together, they share a vision of exploring and harnessing the healing properties of natural extracts and contributing to the medical field through innovative research.
Conclusion
Dong-Gun Kim's work in developing a pharmaceutical composition using maple leaf extract showcases the intersection of nature and modern medicine. His contributions are paving the way for novel approaches to treating retinal diseases, providing hope for improved health outcomes for those affected. With his ongoing research and collaborative efforts, Kim stands out as a promising inventor in the pharmaceutical landscape.